DK0811058T3 - Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder - Google Patents

Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder

Info

Publication number
DK0811058T3
DK0811058T3 DK96904778T DK96904778T DK0811058T3 DK 0811058 T3 DK0811058 T3 DK 0811058T3 DK 96904778 T DK96904778 T DK 96904778T DK 96904778 T DK96904778 T DK 96904778T DK 0811058 T3 DK0811058 T3 DK 0811058T3
Authority
DK
Denmark
Prior art keywords
pct
biological sources
factor
sec
preparing factor
Prior art date
Application number
DK96904778T
Other languages
English (en)
Inventor
Djuro Josic
Lutz Hoffer
Frank Morfeld
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK0811058T3 publication Critical patent/DK0811058T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
DK96904778T 1995-02-25 1996-02-14 Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder DK0811058T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19506633A DE19506633A1 (de) 1995-02-25 1995-02-25 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
PCT/EP1996/000636 WO1996027003A1 (en) 1995-02-25 1996-02-14 A process for the preparation of factor ix from biological sources

Publications (1)

Publication Number Publication Date
DK0811058T3 true DK0811058T3 (da) 2000-10-16

Family

ID=7755037

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96904778T DK0811058T3 (da) 1995-02-25 1996-02-14 Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder

Country Status (20)

Country Link
US (1) US5919909A (da)
EP (1) EP0811058B1 (da)
JP (1) JPH11500910A (da)
KR (1) KR100436857B1 (da)
CN (1) CN1105779C (da)
AT (1) ATE194167T1 (da)
AU (1) AU697217B2 (da)
CA (1) CA2213577C (da)
DE (2) DE19506633A1 (da)
DK (1) DK0811058T3 (da)
EA (1) EA000222B1 (da)
ES (1) ES2147365T3 (da)
FI (1) FI119377B (da)
GR (1) GR3034035T3 (da)
IL (1) IL117157A (da)
MY (1) MY119366A (da)
PT (1) PT811058E (da)
UA (1) UA46005C2 (da)
WO (1) WO1996027003A1 (da)
ZA (1) ZA961450B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
WO2005033140A1 (ja) * 2003-09-30 2005-04-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 高純度血液凝固ｉｘ因子調製物およびその精製方法
KR100567448B1 (ko) * 2003-11-05 2006-04-04 주식회사 인투젠 형질전환 동물의 유즙 전처리방법 및 이를 통한 인체단백질의 정제방법
EP1755652B1 (en) * 2004-03-19 2010-11-24 Baxter International Inc. Factor ixa for the treatment of bleeding disorders
US10928366B2 (en) * 2007-01-26 2021-02-23 Sigma-Aldrich Co. Llc Compositions and methods for combining protein precipitation and solid phase extraction
US10434492B2 (en) * 2007-01-26 2019-10-08 Sigma-Aldrich Co. Llc Compositions and methods for solid phase extraction of lipids
WO2011121020A1 (en) * 2010-03-30 2011-10-06 Octapharma Ag A process for purifying vitamin k dependent proteins such as coagulation factor ix
CN104560925B (zh) * 2014-12-30 2017-11-03 山东泰邦生物制品有限公司 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法
CN107540743A (zh) * 2017-10-11 2018-01-05 南岳生物制药有限公司 一种双层析法制备人纤维蛋白原的方法
CN111378029B (zh) * 2018-12-29 2023-05-05 四川远大蜀阳药业有限责任公司 一种人凝血因子ix的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
DE69231401T2 (de) * 1991-03-01 2001-02-08 Rhone-Poulenc Rorer International (Holdings) Inc., Greenville Herstellung von faktor-ix
CN1064552C (zh) 1993-02-09 2001-04-18 奥克塔法马有限公司 失活无脂质被膜病毒的方法
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen

Also Published As

Publication number Publication date
UA46005C2 (uk) 2002-05-15
EP0811058B1 (en) 2000-06-28
KR100436857B1 (ko) 2004-09-21
FI119377B (fi) 2008-10-31
PT811058E (pt) 2000-10-31
DE69609054T2 (de) 2001-03-08
EP0811058A1 (en) 1997-12-10
FI973469L (fi) 1997-08-22
KR19980702453A (ko) 1998-07-15
EA199700196A1 (ru) 1998-02-26
ATE194167T1 (de) 2000-07-15
GR3034035T3 (en) 2000-11-30
ES2147365T3 (es) 2000-09-01
US5919909A (en) 1999-07-06
AU697217B2 (en) 1998-10-01
EA000222B1 (ru) 1998-12-24
CA2213577A1 (en) 1996-09-06
DE69609054D1 (de) 2000-08-03
ZA961450B (en) 1996-08-27
WO1996027003A1 (en) 1996-09-06
IL117157A0 (en) 1996-06-18
IL117157A (en) 1999-12-22
JPH11500910A (ja) 1999-01-26
AU4876196A (en) 1996-09-18
FI973469A0 (fi) 1997-08-22
CN1105779C (zh) 2003-04-16
MY119366A (en) 2005-05-31
CA2213577C (en) 2005-01-04
CN1181782A (zh) 1998-05-13
DE19506633A1 (de) 1996-08-29

Similar Documents

Publication Publication Date Title
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
DE59713049D1 (de) Verfahren zur Herstellung von Cyclischen Amin substituierten Phenyl-alkyl-Ketonen
ATE226641T1 (de) Humaner 4-1bb spezifischer humaner antikörper und diesen produzierende zellinie
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
DK0811058T3 (da) Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder
DE60011396D1 (de) Verfahren zur herstellung von iopamidol
DK0787124T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aminobenzonitriler
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
SE9601600D0 (sv) Improved process
ATE203408T1 (de) Verbessertes verfahren zur herstellung von 6,
ATE227725T1 (de) Verfahren zur herstellung von galanthanin
DE50300920D1 (de) Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
DE59603295D1 (de) Verfahren zur herstellung von dolastatin 15 und deren zwischenprodukten
ATE186737T1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden
DE69939751D1 (de) Verfahren zur Herstellung von S-Aryl-Cystein
ATE239695T1 (de) Stereoselektive verfahren zur herstellung von gabapentinanalogen
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
DE59008482D1 (de) Verfahren zur Herstellung von 2,4,5-Triamino-6-hydroxypyrimidin durch katalytische Hydrierung von 2,4-Diamino-6-hydroxy-5-nitrosopyrimidin.
DE59809481D1 (de) Verfahren zur Herstellung von Aminocyanacetamid
DE50001638D1 (de) Verfahren zur herstellung von 4,6-dichlorpyrimidin
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE281428T1 (de) Verfahren zur herstellung von methoxyimino- essigsäureamiden
EA200000705A1 (ru) Промежуточные соединения и способ синтеза 17-замещенных 16.бета.-арилокси 4-азастероидов
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1